Latest updates for Optscureal Limited

Fresh curated links around Optscureal Limited are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS
  • OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

newswire.com /2 weeks ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

Read source
newswire.com /2 weeks ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

Read source
newswire.com /3 weeks ago

OSR Holdings Is Now OSR Health - A New Name That Says Exactly What We Do

OSR Holdings is now OSR Health, reflecting its mission to advance healthcare innovation across biotechnology, medical technology and wellness markets.

Read source
investing.com /1 month ago

Form 4 Ocular Therapeutix Inc For: 12 June

Read source
fool.com /1 month ago

Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1

Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.

Read source
newswire.com /1 month ago

CEO Statement to Shareholders

OSR Holdings CEO update on Nasdaq compliance, strategic biotech portfolio progress, and long-term value creation across subsidiaries in 2026

Read source
newswire.com /1 month ago

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level

Read source
amrc.org.uk /1 month ago

Ocular Melanoma UK

www.omuk.org

Read source
newswire.com /1 week ago

Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

Read source
seekingalpha.com /1 month ago

hVIVO plc (OPORF) Analyst/Investor Day - Slideshow

Read source
newswire.com /2 days ago

OSR Health, A Message From the CEO

Read the CEO’s letter outlining OSR Health’s proposed Shareholder Loyalty CVR Program, VXM01 progress, Woori IO and the company’s long-term strategy

Read source
investing.com /4 weeks ago

Form 4 Oncotelic Therapeutics Inc For: 17 June

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Optscureal Limited

seekingalpha.com

Recent coverage from public sources
Public source

amrc.org.uk

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

investing.com

Recent coverage from public sources
Public source

newswire.com

Recent coverage from public sources
Public source